Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Catumaxomab

First report of inflammatory lesions of the peritoneum following intraperitoneal administration: case report

    • 12 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Russel J, Stein A, Behrmann C, Hauptmann S, Krummenerl P, Schmoll H-J, Arnold D.Inflammatory lesions of the peritoneum mimic carcinomatosis after treatment with intravenous chemotherapy and intraperitoneal catumaxomab. Journal of Clinical Oncology 29: e644-e646, No. 22, Aug 2011. Available from: URL: http://dx.doi.org/10.1200/jco.2010.34.3939 - Germany

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Catumaxomab. React. Wkly. 1372, 11–12 (2011). https://doi.org/10.2165/00128415-201113720-00030

    Download citation

    Keywords

    • Capecitabine
    • Epirubicin
    • Peritoneal Carcinomatosis
    • Colon Wall
    • Partial Thickening